Ross Jakes
Impact in
- Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neurological disorders and treatments
- Physiology top 0.02%
- Alzheimer's disease research and treatments
Papers in
- Physiology 57
- Alzheimer's disease research and treatments 54
-
- Prion Diseases and Protein Misfolding 14
- Protein Structure and Dynamics 7
- Co-authors
- Michel Goedert (64 shared papers)Maria Grazia Spillantini (18 shared papers)R. Anthony Crowther (27 shared papers)Masato Hasegawa (7 shared papers)Michael J. Smith (8 shared papers)John Q. Trojanowski (5 shared papers)Philip Cohen (7 shared papers)Eugeen Vanmechelen (4 shared papers)
- Journals
- FEBS Letters (15 papers)Proceedings of the National Academy of Sciences (10 papers)Journal of Biological Chemistry (7 papers)Biochemistry (5 papers)Biochemical Journal (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ross Jakes
99 papers receiving 22.9k citations
Ross Jakes's Hit Papers
Peers
Comparison fields: 5 of 143
- Neurology 8.8k
- Physiology 13.8k
- Neurology 4.2k
- Cellular and Molecular Neuroscience 6.5k
- Cell Biology 3.5k
Countries citing papers authored by Ross Jakes
This map shows the geographic impact of Ross Jakes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Jakes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Jakes more than expected).
Fields of papers citing papers by Ross Jakes
This network shows the impact of papers produced by Ross Jakes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Jakes. The network helps show where Ross Jakes may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross Jakes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies Hit paper breakdown → | 1998 | 2625 |
| 2 | Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Hit paper breakdown → | 1989 | 2069 |
| 3 | Identification of two distinct synucleins from human brain Hit paper breakdown → | 1994 | 924 |
| 4 | Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans Hit paper breakdown → | 1996 | 873 |
| 5 | Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Hit paper breakdown → | 1998 | 851 |
| 6 | Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Hit paper breakdown → | 1988 | 826 |
| 7 | Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding Hit paper breakdown → | 1993 | 793 |
| 8 | Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. Hit paper breakdown → | 1990 | 769 |
| 9 | Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation Hit paper breakdown → | 2000 | 670 |
| 10 | Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein Hit paper breakdown → | 2002 | 583 |
| 11 | Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 Hit paper breakdown → | 1995 | 509 |
| 12 | 1998 | 461 | |
| 13 | 1988 | 456 | |
| 14 | The Synucleinopathies: Twenty Years On Hit paper breakdown → | 2017 | 434 |
| 15 | 1994 | 414 | |
| 16 | 2002 | 409 | |
| 17 | 1993 | 399 | |
| 18 | 1994 | 369 | |
| 19 | 1995 | 365 | |
| 20 | 1998 | 360 |
About Ross Jakes
Ross Jakes is a scholar working on Physiology, Molecular Biology, Neurology, Cell Biology and Cellular and Molecular Neuroscience, having authored 99 papers that have together received 23.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (54 papers), Parkinson's Disease Mechanisms and Treatments (27 papers), Microtubule and mitosis dynamics (17 papers), Prion Diseases and Protein Misfolding (14 papers), Neurological diseases and metabolism (12 papers), Neuroscience and Neuropharmacology Research (10 papers), Neurological disorders and treatments (10 papers) and Protein Structure and Dynamics (7 papers). The work is most often cited by research in Neurology (8.8k citations), Physiology (13.8k citations), Neurology (4.2k citations), Cellular and Molecular Neuroscience (6.5k citations) and Cell Biology (3.5k citations). Ross Jakes has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michel Goedert, Maria Grazia Spillantini, R. Anthony Crowther, Masato Hasegawa, Michael J. Smith, John Q. Trojanowski, Philip Cohen, Eugeen Vanmechelen, John Kendrick‐Jones and M. G. Spillantini. Their work appears in journals such as FEBS Letters, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Biochemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.